98 related articles for article (PubMed ID: 30563826)
1. Performance of Single-Nucleotide Polymorphisms in Breast Cancer Risk Prediction Models: A Systematic Review and Meta-analysis.
Fung SM; Wong XY; Lee SX; Miao H; Hartman M; Wee HL
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):506-521. PubMed ID: 30563826
[TBL] [Abstract][Full Text] [Related]
2. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
Mealiffe ME; Stokowski RP; Rhees BK; Prentice RL; Pettinger M; Hinds DA
J Natl Cancer Inst; 2010 Nov; 102(21):1618-27. PubMed ID: 20956782
[TBL] [Abstract][Full Text] [Related]
3. Polygenic risk prediction models for colorectal cancer: a systematic review.
Sassano M; Mariani M; Quaranta G; Pastorino R; Boccia S
BMC Cancer; 2022 Jan; 22(1):65. PubMed ID: 35030997
[TBL] [Abstract][Full Text] [Related]
4. Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model.
Dite GS; Mahmoodi M; Bickerstaffe A; Hammet F; Macinnis RJ; Tsimiklis H; Dowty JG; Apicella C; Phillips KA; Giles GG; Southey MC; Hopper JL
Breast Cancer Res Treat; 2013 Jun; 139(3):887-96. PubMed ID: 23774992
[TBL] [Abstract][Full Text] [Related]
5. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.
Gail MH
J Natl Cancer Inst; 2008 Jul; 100(14):1037-41. PubMed ID: 18612136
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry.
Dite GS; MacInnis RJ; Bickerstaffe A; Dowty JG; Allman R; Apicella C; Milne RL; Tsimiklis H; Phillips KA; Giles GG; Terry MB; Southey MC; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):359-65. PubMed ID: 26677205
[TBL] [Abstract][Full Text] [Related]
7. Validation of a genetic risk score for Arkansas women of color.
Starlard-Davenport A; Allman R; Dite GS; Hopper JL; Spaeth Tuff E; Macleod S; Kadlubar S; Preston M; Henry-Tillman R
PLoS One; 2018; 13(10):e0204834. PubMed ID: 30281645
[TBL] [Abstract][Full Text] [Related]
8. Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model.
Gail MH
J Natl Cancer Inst; 2009 Jul; 101(13):959-63. PubMed ID: 19535781
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the effect of multiple genetic risk score models on colorectal cancer risk prediction.
Xin J; Chu H; Ben S; Ge Y; Shao W; Zhao Y; Wei Y; Ma G; Li S; Gu D; Zhang Z; Du M; Wang M
Gene; 2018 Oct; 673():174-180. PubMed ID: 29908285
[TBL] [Abstract][Full Text] [Related]
10. SNPs and breast cancer risk prediction for African American and Hispanic women.
Allman R; Dite GS; Hopper JL; Gordon O; Starlard-Davenport A; Chlebowski R; Kooperberg C
Breast Cancer Res Treat; 2015 Dec; 154(3):583-9. PubMed ID: 26589314
[TBL] [Abstract][Full Text] [Related]
11. NanoString-based breast cancer risk prediction for women with sclerosing adenosis.
Winham SJ; Mehner C; Heinzen EP; Broderick BT; Stallings-Mann M; Nassar A; Vierkant RA; Hoskin TL; Frank RD; Wang C; Denison LA; Vachon CM; Frost MH; Hartmann LC; Aubrey Thompson E; Sherman ME; Visscher DW; Degnim AC; Radisky DC
Breast Cancer Res Treat; 2017 Nov; 166(2):641-650. PubMed ID: 28798985
[TBL] [Abstract][Full Text] [Related]
12. Association of CYP2E1, STK15 and XRCC1 Polymorphisms with Risk of Breast Cancer in Malaysian Women.
Chong ET; Goh LP; See EU; Chuah JA; Chua KH; Lee PC
Asian Pac J Cancer Prev; 2016; 17(2):647-53. PubMed ID: 26925658
[TBL] [Abstract][Full Text] [Related]
13. Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model.
Marcus MW; Raji OY; Duffy SW; Young RP; Hopkins RJ; Field JK
Int J Oncol; 2016 Jul; 49(1):361-70. PubMed ID: 27121382
[TBL] [Abstract][Full Text] [Related]
14. Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors.
Bruzelius M; Bottai M; Sabater-Lleal M; Strawbridge RJ; Bergendal A; Silveira A; Sundström A; Kieler H; Hamsten A; Odeberg J
J Thromb Haemost; 2015 Feb; 13(2):219-27. PubMed ID: 25472531
[TBL] [Abstract][Full Text] [Related]
15. Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models.
Ming C; Viassolo V; Probst-Hensch N; Chappuis PO; Dinov ID; Katapodi MC
Breast Cancer Res; 2019 Jun; 21(1):75. PubMed ID: 31221197
[TBL] [Abstract][Full Text] [Related]
16. Improving breast cancer risk prediction by using demographic risk factors, abnormality features on mammograms and genetic variants.
Feld SI; Woo KM; Alexandridis R; Wu Y; Liu J; Peissig P; Onitilo AA; Cox J; Page CD; Burnside ES
AMIA Annu Symp Proc; 2018; 2018():1253-1262. PubMed ID: 30815167
[TBL] [Abstract][Full Text] [Related]
17. Association of single nucleotide polymorphisms in FGF-RAS/MAP signalling cascade with breast cancer susceptibility.
Dankova Z; Zubor P; Grendar M; Kapinova A; Zelinova K; Jagelkova M; Gondova A; Dokus K; Kalman M; Lasabova Z; Danko J
Gen Physiol Biophys; 2017 Dec; 36(5):565-572. PubMed ID: 29372690
[TBL] [Abstract][Full Text] [Related]
18. Genetic predisposition to early recurrence in clinically localized prostate cancer.
Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
[TBL] [Abstract][Full Text] [Related]
19. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.
McCarthy AM; Keller B; Kontos D; Boghossian L; McGuire E; Bristol M; Chen J; Domchek S; Armstrong K
Breast Cancer Res; 2015 Jan; 17(1):1. PubMed ID: 25567532
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
